Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system
Inhibition of the mechanistic target of rapamycin (mTOR) signaling pathway by the FDA-approved drug rapamycin has been shown to promote lifespan and delay age-related diseases i...